Moderna (MRNA) Climbs 16% as Arbutus-Genevant Legal Battle Clears
Moderna snapped a two-day losing streak on Wednesday, jumping 15.99 percent to finish at $57.80 apiece after resolving a four-year legal dispute with two biopharmaceutical companies in relation to an ...






